Maxpro
Finance · Taiwan · 1-10 Employees
View Company Info for Free
Overview
Headquarters
5/f-4 No. 89 Songren Rd, Xinyi District,...Phone Number
+886 277137952Website
www.maxproventures.comRevenue
<$5 MillionStock Symbol
JMACIndustry
About Maxpro
Maxpro Org Chart
Is Maxpro your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Maxpro recently announced quarterly report
Check if Maxpro has recently received funding, and reach out quickly before it becomes old news!
Click to see if Maxpro had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Maxpro has new funding data
Maxpro, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Maxpro launches new products
Congratulate Masked Content for being promoted to Masked Content at Maxpro
Check out if Maxpro is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Maxpro is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
Maxpro is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Maxpro.
Maxpro Tech Stack
A closer look at the technologies used by Maxpro
Maxpro News & Media
Maxpro Capital Acquisition Corp. Announces Extension to Deadline to Complete Business Combination
TAIPEI CITY, Jan. 10, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Maxpro Capital Acquisition Corp. (NASDAQ: JMAC) (the “Company”), announced today that its sponsor, MP One Investment LLC (the “Sponsor”), has requested that the Company extend the date by which the Company has to consummate a business combination from January 13, 2023 to April 13, 2023 (the “Extension”). The Extension is the second of two three-month extensions permitted under the Company’s governing documents. In connectionApollomics Inc. Receives FDA Orphan Drug Designation for Vebreltinib (APL-101) for Treatment of Non-Small Cell Lung Cancer with MET Genomic Tumor Aberrations
FOSTER CITY, Calif., Nov. 15, 2022 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: JMAC), an innovative biopharmaceutical company committed to the discovery and development of mono- and combination-oncology therapies, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to vebreltinib (APL-101) for the treatment of non-small cell lung cancer (NSCLC) with MET genomic tumor aberrations. The FDA granted the Orphan Drug Designation in August.Maxpro Capital Acquisition Corp. Confirms Additional Funding and Extension of Deadline to Complete Initial Business Combination
TAIPEI CITY, Oct. 14, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Maxpro Capital Acquisition Corp. (NASDAQ: JMAC) (the “Company”) announced today that its sponsor, MP One Investment LLC (the “Sponsor”), deposited an additional payment in the aggregate amount of $1,035,000 (representing $0.10 per public share) (the “Extension Payment”) into the Company’s trust account for its public stockholders. This deposit enables the Company to extend the date by which the Company has to complete its initialMaxpro Capital Acquisition Corp. Announces Extension to Deadline to Complete Business Combination
Taipei City, Oct. 07, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Maxpro Capital Acquisition Corp. (NASDAQ: JMAC) (the “Company”), announced today that its sponsor, MP One Investment LLC (the “Sponsor”), has requested that the Company extend the date by which the Company has to consummate a business combination from October 13, 2022 to January 13, 2023 (the “Extension”). The Extension is the first of two three-month extensions permitted under the Company’s governing documents. In connection
Top Finance Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Maxpro
Maxpro Investment is one of the best asset management company in Asia. Our service includes closed-end private equity fund and special financial account management for the institutional and high net worth investors. For the past years, Maxpro Investment does not just deliver high returns but also steady and perpetual returns to our investors.... Read More